Brighter Outlook for Kidney Transplantation
The emphasis throughout this volume has been on maintenance of renal failure patients with dialysis; nonetheless, it is evident that the best survival, and certainly the best quality of survival for these patients, is dependent on the integration of two complementary therapies: transplantation and dialysis. The surgical contribution to the management of the patient with end-stage renal failure begins with the establishment of an access for dialysis. Once a dependable access has been developed, the best results are seen in a self-dialysis setting, either home hemodialysis or peritoneal dialysis (CAPD). Undoubtedly, access is the backbone of dialytic therapy.
KeywordsGraft Survival Antithymocyte Globulin Total Lymphoid Irradiation Downstate Medical Home Hemodialysis
Unable to display preview. Download preview PDF.
- 1.Opelz G, Terasaki PI: Cadaver kidney transplants in North America: Analysis 1978. Daily Transplant 8: 167–181, 1979.Google Scholar
- 2.Van Es AA, Balner H: Effect of pretransplant transfusions on kidney allograft survival. Transplant Proceed 11: 127–137, 1979.Google Scholar
- 3.Hunsicker LG, Oei LS, Freeman RM, et al: Effect of blood transfusions on cadaver renal allograft survival. Transplant Proceed 11: 156–159. 1979.Google Scholar
- 4.Williams KA, Ting A, Cullen PR, et al: Transfusions: Their influence on human renal graft survival. Transplant Proceed 11: 175–178, 1979.Google Scholar
- 5.Salvatierra, O Jr, Amend W, Vincenti F, et al: Pretreatment with donor-specific blood transfusions in related recipients with high MLC. Transplant Proceed 13: 142–149, 1981.Google Scholar
- 7.Wasnick RJ, Butt KMH, Laungani G, et al: Evaluation of anterior extravesical ureteroneocystostomy in kidney transplantation. J Urology 126: 306–307, 1981.Google Scholar
- 9.Parsa I, Butt KMH, Sutton AL, et al: HLA-DR, antithymocyte globulin (ATG) and survival of cadaveric renal allografts. Transplant Proceed 13: 495–498, 1981.Google Scholar